Jagsonpal Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE048B01035
  • NSEID: JAGSNPHARM
  • BSEID: 507789
INR
207.55
-2.15 (-1.03%)
BSENSE

Nov 20

BSE+NSE Vol: 19.96 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 134241,
    "name": "Jagsonpal Pharma",
    "stock_name": "Jagsonpal Pharma",
    "full_name": "Jagsonpal Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/jagsonpal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "207.55",
    "chg": -2.15,
    "chgp": "-1.03%",
    "dir": -1,
    "prev_price": "209.70",
    "mcapval": "1,374.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 507789,
    "symbol": "JAGSNPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE048B01035",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "19.96 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/jagsonpal-pharma-134241-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jagsonpal Pharmaceuticals Ltd is Rated Hold",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/jagsonpal-pharmaceuticals-ltd-is-rated-hold-4261371",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/JagsonpalPharma_mojoScore_4261371.png",
        "date": "2026-11-14 10:10:28",
        "description": "Jagsonpal Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 8 November 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 November 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Falls 1.41%: Mixed Technicals and Flat Financials Shape the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/jagsonpal-pharmaceuticals-falls-141-mixed-technicals-and-flat-financials-shape-the-week-4256297",
        "imagepath": "",
        "date": "2026-11-08 16:01:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>3 Nov:</strong> Downgrade to Sell rating amid flat financials and sideways technicals</p>\n                    <p><strong>5 Nov:</strong> Technical momentum shifts to mildly bullish despite mixed indicators</p>\n                    <p><strong>6 Nov:</strong> Week closes lower at ₹213.85 (-2.53%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.216.90</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"..."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4251083",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/JagsonpalPharma_technicaldot_4251083.png",
        "date": "2026-11-05 08:00:20",
        "description": "Jagsonpal Pharmaceuticals Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite this positive directional change, a detailed analysis of key technical indicators such as MACD, RSI, moving averages, and volume-based metrics reveals a complex picture that investors should carefully consider before making decisions."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Gains 2.46%: Technical Momentum and Financial Strength Drive Weekly Performance",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/jagsonpal-pharmaceuticals-gains-246-technical-momentum-and-financial-strength-drive-weekly-performance-4246588",
        "imagepath": "",
        "date": "2026-11-01 16:00:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Stock surged 5.53% to Rs.223.40 on upgrade to Hold rating</p>\n                    <p><strong>27 Oct:</strong> Technical momentum shifted to mildly bullish amid mixed indicator signals</p>\n                    <p><strong>29 Oct:</strong> Stock declined 3.51% on higher volume despite Sensex rally</p>\n                    <p><strong>30 Oct:</strong> Week closed at Rs.216.90, down 2.05% on the day but up 2.46% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.211.70</div></div>\n                    <div class=\"stat-item\"><div class=\"..."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-sees-technical-momentum-shift-amid-mixed-indicator-signals-4239825",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/JagsonpalPharma_technicaldot_4239825.png",
        "date": "2026-10-27 08:00:16",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish to a mildly bullish trend, supported by a combination of mixed signals from key technical indicators such as MACD, RSI, and moving averages. This development comes alongside a significant 5.53% gain in the stock price, reflecting renewed investor interest in the micro-cap pharmaceutical player."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Declines 3.33%: Technical Shifts and Valuation Concerns Shape Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/jagsonpal-pharmaceuticals-declines-333-technical-shifts-and-valuation-concerns-shape-week-4238033",
        "imagepath": "",
        "date": "2026-10-25 16:00:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>19 Oct:</strong> Downgrade to Sell rating by MarketsMOJO</p>\n                    <p><strong>21 Oct:</strong> Technical momentum shifts to sideways trend</p>\n                    <p><strong>23 Oct:</strong> Further technical deterioration to mildly bearish stance</p>\n                    <p><strong>23 Oct:</strong> Week closes at ₹211.70 (-3.33%) vs Sensex (-3.75%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹219.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹211.70</div><div class..."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Faces Technical Momentum Shift Amid Bearish Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-faces-technical-momentum-shift-amid-bearish-signals-4234434",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/JagsonpalPharma_technicaldot_4234434.png",
        "date": "2026-10-23 08:00:17",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, prompting a downgrade from Hold to Sell by MarketsMOJO on 19 Oct 2026. The micro-cap pharmaceutical firm’s share price has declined by 3.6% on the day, reflecting a broader mildly bearish trend across key technical indicators despite some longer-term bullish signals."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/jagsonpal-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicators-4231154",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/JagsonpalPharma_technicaldot_4231154.png",
        "date": "2026-10-21 08:00:36",
        "description": "Jagsonpal Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, signalling a cautious outlook for investors amid mixed signals and a recent downgrade in its Mojo Grade to Sell."
      },
      {
        "title": "Jagsonpal Pharmaceuticals Downgraded to Sell Amid Mixed Financials and Weak Technicals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/jagsonpal-pharmaceuticals-downgraded-to-sell-amid-mixed-financials-and-weak-technicals-4230630",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/JagsonpalPharma_mojoScore_4230630.png",
        "date": "2026-10-20 08:21:24",
        "description": "Jagsonpal Pharmaceuticals Ltd has seen its investment rating downgraded from Hold to Sell as of 19 Oct 2026, reflecting a shift in technical indicators and valuation metrics despite recent positive quarterly financial results. The downgrade is driven by a combination of deteriorating technical trends, expensive valuation, modest long-term growth, and mixed financial performance, signalling caution for investors in this micro-cap pharmaceutical stock."
      }
    ],
    "total": 55,
    "sid": "134241",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/jagsonpal-pharmaceuticals-134241"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "03-Nov-2026",
      "details": "Earning call transcript for Jagsonpal Pharmaceuticals Limited Q2 FY 27 Earning Conference Call on October 29 2026 at 2:00 P.M",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "29-Oct-2026",
      "details": "Audio Recording of Jagsonpal Pharmaceuticals Limited Q2 FY27",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "29-Oct-2026",
      "details": "Newspaper Publication providing extracts of Unaudited Results of Company for the quarter and half ended September 30 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has declared <strong>200%</strong> dividend, ex-date: 04 Sep 26",
          "dt": "2026-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Jagsonpal Pharmaceuticals Ltd has announced <strong>2:5</strong> stock split, ex-date: 08 Jan 25",
          "dt": "2025-01-08",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

03-Nov-2026 | Source : BSE

Earning call transcript for Jagsonpal Pharmaceuticals Limited Q2 FY 27 Earning Conference Call on October 29 2026 at 2:00 P.M

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

29-Oct-2026 | Source : BSE

Audio Recording of Jagsonpal Pharmaceuticals Limited Q2 FY27

Announcement under Regulation 30 (LODR)-Newspaper Publication

29-Oct-2026 | Source : BSE

Newspaper Publication providing extracts of Unaudited Results of Company for the quarter and half ended September 30 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Jagsonpal Pharmaceuticals Ltd has declared 200% dividend, ex-date: 04 Sep 26

stock-summary
SPLITS

Jagsonpal Pharmaceuticals Ltd has announced 2:5 stock split, ex-date: 08 Jan 25

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available